Valentina Luzzi

Dr. Valentina Luzzi

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
LGLuca Gozzi
Luca Gozzi
DCDiletta Cozzi
Diletta Cozzi
ECEDOARDO CAVIGLI
EDOARDO CAVIGLI
CMChiara Moroni
Chiara Moroni
CGCaterina Giannessi
Caterina Giannessi
VMVittorio Miele
Vittorio Miele
Lymphoproliferative lung diseases are a heterogeneous group of disorders characterized by primary or secondary involvement of the lung. Primary pulmonary lymphomas are the most common type, representing 0.5–1% of all primary malignancies of the lung. The radiological presentation is often heterogeneous and non-specific: consolidations, masses, and nodules are the most common findings, followed by ground-glass opacities and interstitial involvement, more common in secondary lung lymphomas. These findings usually show a prevalent perilymphatic spread along bronchovascular bundles, without a prevalence in the upper or lower lung lobes. An ancillary sign, such as a “halo sign”, “reverse halo sign”, air bronchogram, or CT angiogram sign, may be present and can help rule out a differential diagnosis. Since a wide spectrum of pulmonary parenchymal diseases may mimic lymphoma, a correct clinical evaluation and a multidisciplinary approach are mandatory. In this sense, despite High-Resolution Computer Tomography (HRCT) representing the gold standard, a tissue sample is needed for a certain and definitive diagnosis. Cryobiopsy is a relatively new technique that permits the obtaining of a larger amount of tissue without significant artifacts, and is less invasive and more precise than surgical biopsy.

1 July 2019 in Panminerva Medica
Verified
Journal Article
Closed access
MBMichela Bezzi
Michela Bezzi
VLValentina Luzzi
Valentina Luzzi
MNMauro Novali
Mauro Novali
ACAndrea Comel
Andrea Comel
GPGuido Polese
Guido Polese
LCLorenzo Corbetta
Lorenzo Corbetta
Bronchoscopic lung volume reduction (BLVR) has been proven to be effective in patients with severe emphysema. These techniques are divided into two groups: non-blocking devices that are independent of collateral ventilation and blocking devices that are dependent on collateral ventilation so the choice of the target lobe with inadequate scissors is crucial for the success of the treatment. Current evidences suggest that not all classes and phenotypes of emphysema will benefit from BLVR, and that each technique appears to provide a greater benefit to specific sub-groups of patients. Careful patient selection is imperative to prevent insertion in patients unlikely to gain clinical benefits as well as wasteful expenditure. The Chartis system represents the gold standard for measuring fissure integrity and is a direct measurement method. Indirect method is instead the TC study which, thanks to the development of software for quantitative analysis, allows us to obtain reliable measurements of regional density of parenchyma, airway thickness and scissor integrity. BLVR is a highly complex procedure: a first-level competence is a pre-requisite for admission to training. The practical training must be based on discussion of clinical cases and the insertion techniques of the different devices on plastic or animal models, or on cadavers. A specific course, offering final certification, has been developed on the use of Zephyr valves.

15 July 2025 in Breathe
Verified
Journal Article
Open access
VLValentina Luzzi
Valentina Luzzi
ALAnna L. Lindahl
Anna L. Lindahl
STSara Tomassetti
Sara Tomassetti
This narrative review explores the complementary roles of indwelling pleural catheters (IPCs) and medical thoracoscopy (MT) in the evaluation and management of unexplained exudative pleural effusions, including malignant pleural effusion. IPCs offer a minimally invasive strategy for long-term outpatient management, which is particularly advantageous for patients with non-expandable lungs or limited functional status. Conversely, MT remains the gold standard for diagnostic accuracy and facilitates therapeutic procedures such as pleurodesis under direct visualisation. Recent evidence supports the integration of IPCs and MT as a hybrid approach, offering synergistic benefits including enhanced symptom control, reduced hospital admissions and improved patient-centred outcomes. This review synthesises current literature to provide a practical and evidence-based overview of these techniques and their evolving role in pleural disease management.

2 March 2025 in Monaldi Archives for Chest Disease
Verified
Journal Article
Open access
PDF file
KAKshitij Agarwal
Kshitij Agarwal
AGAdam T. Gray
Adam T. Gray
TTTudor P. Toma
Tudor P. Toma
VLValentina Luzzi
Valentina Luzzi
LCLorenzo Corbetta
Lorenzo Corbetta
The management of tuberculosis (TB) presents significant challenges, particularly in the context of multidrug-resistant TB (MDR-TB) and TB-HIV co-infection. Traditional surgical interventions, such as lung resection and pneumothorax induction, have largely been phased out with the advent of modern antibiotic regimens. However, emerging evidence suggests that endobronchial interventions, specifically the use of unidirectional valves, have potential in supporting the treatment of MDR-TB. The objective of this review is to demonstrate the feasibility of closure of tubercular cavities using endobronchial valves, resulting in improved clinical outcomes and sputum smear conversion. PubMed was searched from inception to September 2024. The small studies reviewed here demonstrate the feasibility of tubercular cavity closure using endobronchial valves, resulting in improved clinical outcomes and sputum smear conversion. Yet, limited access to Food and Drug Administration-approved valves and funding challenges hinders large-scale trials. To address these limitations, further evidence is needed within improved international collaboration. We suggest that international prospective trials and innovation are needed. Such collaborative efforts would clarify the role of valves in TB treatment and hopefully lead to the development of simpler and more affordable occlusive devices that would benefit patients with MDR-TB, particularly in low-income countries.

9 September 2023 in European Respiratory Journal
Verified
Conference Paper
Closed access
VLValentina Luzzi
Valentina Luzzi
BPBianca Peixoto
Bianca Peixoto
MTMarco Trigiani
Marco Trigiani
LCLuca Ciani
Luca Ciani
LGLeonardo Giuntoli
Leonardo Giuntoli
STSara Tomassetti
Sara Tomassetti
Introduction: Stereotactic body radiotherapy (SBRT) is a treatment option for early-stage lung cancer, especially in patients unfit for surgery, and intrathoracic oligo-metastatic disease. SBRT may benefit from intralesional placement of radio-opaque fiducial markers (FM) to ensure precise dose delivery and avoid radiation injury to mediastinal organs. We present a case series of 7 FM’s placement by endobronchial ultrasound (EBUS) in patients with metastatic involvement of intrathoracic lymph nodes (LN) and preliminary results. Case Report: 7 patients were referred for FM placement via EBUS, with general anesthesia and via rigid bronchoscopy. The target LN were visualized with EBUS. After that, the needle’s stylet was partially withdrawn and the FM was introduced inside the needle. The LN was located again and punctured with the FM loaded needle. The stylet was advanced into the needle, deploying the FM under fluoroscopy. This procedure was repeated 2 times more in order to place 3 FMs in each lymph node in a triangle shape. SBRT was performed using FM-guided real-time tumor tracking with the CyberKnife Robotic radiosurgery system. A median of 3 fiducial markers were implanted. The median of total dose administered was 37 Gy. After the FM placement, no adverse events (AE), migration or malfunction. Conclusion: SBRT delivers high radiation doses and the FM is used to mark and track the target during the treatment session and account for tumor motion. Preliminary results showed promising efficacy in selected patients due to the possibility to deliver higher radiation dose directly to the target avoid healthy tissue.

19 July 2024 in Medicine
Verified
Journal Article
Open access
Cosimo NardiCosimo Nardi
Cosimo Nardi
AMAndrea Magnini
Andrea Magnini
VRVieri Rastrelli
Vieri Rastrelli
GZGIULIA ZANTONELLI
GIULIA ZANTONELLI
LCLinda Calistri
Linda Calistri
SCStefano Colagrande
Stefano Colagrande
Broncho-alveolar lavage (BAL) is indicated in cases of uncertain diagnosis but high suspicion of Sars-Cov-2 infection allowing to collect material for microbiological culture to define the presence of coinfection or super-infection. This prospective study investigated the correlation between chest computed tomography (CT) findings, Covid-19 Reporting and Data System score, and clinical outcomes in Coronavirus disease 2019 (Covid-19) patients who underwent BAL with the aim of predicting outcomes such as lung coinfection, respiratory failure, and hospitalization length based on chest CT abnormalities. Study population included 34 patients (range 38–90 years old; 20 males, 14 females) with a positive nucleic acid amplification test for Covid-19 infection, suitable BAL examination, and good quality chest CT scan in the absence of lung cancer history. Pulmonary coinfections were found in 20.6% of patients, predominantly caused by bacteria. Specific correlations were found between right middle lobe involvement and pulmonary co-infections. Severe lung injury (PaO2/FiO2 ratio of 100–200) was associated with substantial involvement of right middle, right upper, and left lower lobes. No significant correlation was found between chest CT findings and inflammatory markers (C-reactive protein, procalcitonin) or hospitalization length of stay. Specific chest CT patterns, especially in right middle lobe, could serve as indicators for the presence of co-infections and disease severity in noncritically ill Covid-19 patients, aiding clinicians in timely interventions and personalized treatment strategies.